ConstruxBoy
Kate's Daddy
FWIW - Been looking at Biosimilar companies in the drug segment. All of the main players have some of these in the pipeline:
Link
Mylan NV seems to be out ahead to some degree and they have an interesting next few days as they are merging with Pfizer's Upjohn segment into a new company called Viatris. Upjohn has some legacy drugs that are winding down but can act as a cash cow and knowledgebase to help push Mylan's biosimilars forward. All PFE and MYL shareholders as of close tomorrow get an equal number of VTRS shares on Monday. Might be worth a look.
Link
Mylan NV seems to be out ahead to some degree and they have an interesting next few days as they are merging with Pfizer's Upjohn segment into a new company called Viatris. Upjohn has some legacy drugs that are winding down but can act as a cash cow and knowledgebase to help push Mylan's biosimilars forward. All PFE and MYL shareholders as of close tomorrow get an equal number of VTRS shares on Monday. Might be worth a look.